Egypt Hepatitis C Testing Market, By Test (Antibody Test, Genotype Test, Viral Load Test, Others) By Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region, Competition Forecast and Opportunities, 2027
The Egypt Hepatitis C Testing Market is expected to grow at an impressive rate in the forecast period. Hepatitis C is a viral infectious disease affecting the liver, from liver inflammation to liver misfunctioning. It mainly occurs due to the transition of infected, contaminated blood to other healthy bodies through various means. It is challenging to understand HCV in a short period as it takes decades to show the symptoms. The outcome of Hepatitis C disease is well known by people, making them concerned about their health. Hepatitis C Testing Market is going to experience an increase in market share due to awareness and prevention of HCV in Egypt. According to NLM (national library of Medicine) estimation, there will be a downfall of 95% of HCV cases compared to 2013 and going to reach 280,000 in 2030. Hepatitis C is one of the significant reasons for death in Egypt, which is a concern for the people of Egypt. Additionally, Historical mistakes, National and international initiatives, increasing population, and technological advancements or dependence are other reasons that are projected to influence the growth of the market segment through 2027 positively.
Growing awareness about HCV is boosting the market.
According to NLM, one out of ten Egyptians aged between 15-59 suffers from chronic HCV infection, which means they have created antibodies. 7% of the population is affected by chronic Hepatitis C infection, which is 4.1 million. The figure mentioned earlier indicates the impressive market for business as a large number of people are suffering from HCV. Thus, the requirement for medicine and testing kits is going to increase, fulfilling the demand. Ignorance of hepatitis C can lead to liver problems and even liver cancer, a more significant concern for people. In response to saving the life of people, many national and international institutions started campaigning throughout the country to treat hepatitis C patients. As per a survey, out of 1000 people, six increasing people are patients of hepatitis, estimated 170,000 new cases every year to add to the 11.5 million patients suffering from the disease. The National Committee for Control of Viral Hepatitis (NCCVH), the Egyptian government, the public, NGOs, Foreign organizations, the world bank, and different pharmaceutical companies are running initiatives and putting their combined effort into treating HCV. Hence, the measure of the above stakeholder will impact a positive trend in Egypt's market share in the hepatitis C testing market.
The government has launched many initiatives and policies in the healthcare sector, such as conducting the survey, establishing national guidelines & treatment centers, and increasing funding for HCV treatment by up to 90%. These steps will impact HCV treatment and expand the market demand for hepatitis C testing. All the factors mentioned above are expected to drive the expansion of the Hepatitis C Testing Market share.
Lack of Resources
In developing countries like Egypt, NAT Nucleic Acid Amplification Testing is not mandatory due to high costs and the need for high-skilled staff. Price is an essential factor while using and buying any product. If the overall cost is calculated, the labor and testing kit becomes an expensive product.
Merger and Collaboration with international institutions to propel market share
In this market collaboration, a merger is the best method to enter the new market. These help the market use the organization's expertise and others to gather the latest market share.
In December 2021, Roche Egypt LLC and Microsoft Corporation signed MoU. It will help companies improve patient health care using AI & cloud technology and grow their market in the Middle East.
In 2013, The American University in Cairo announced to launch of Egypt's first university spinoff company, 'D-Kimia.' It helps management enter a new market with products or technologies developed at universities in Egypt.
Market Segmentation
Egypt Hepatitis C Testing Market is segmented based on Test, Technique, and End User. Based on the test, the market is divided into Antibody Tests, Genotype Test, Viral Load Tests, and Others. Based on technique, the market is divided into Immunoassays, Polymerase Chain Reactions (PCR), and Others. Based on End Users, the market is divided into Hospitals & Clinics, Diagnostic Laboratories, and Others by company.
Market Players
D-Kimia Diagnostic Solutions, Roche Egypt LLC, Abbott Diagnostic Division Egypt, Qiagen Egypt, Siemens Healthineers Egypt, Bio-Rad Laboratories Egypt, and Thermo Fischer Scientific Egypt are the major market player in Egypt hepatitis C testing market.
Report Scope:
In this report, Egypt Hepatitis C Testing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Egypt Hepatitis C Testing Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Growing awareness about HCV is boosting the market.
According to NLM, one out of ten Egyptians aged between 15-59 suffers from chronic HCV infection, which means they have created antibodies. 7% of the population is affected by chronic Hepatitis C infection, which is 4.1 million. The figure mentioned earlier indicates the impressive market for business as a large number of people are suffering from HCV. Thus, the requirement for medicine and testing kits is going to increase, fulfilling the demand. Ignorance of hepatitis C can lead to liver problems and even liver cancer, a more significant concern for people. In response to saving the life of people, many national and international institutions started campaigning throughout the country to treat hepatitis C patients. As per a survey, out of 1000 people, six increasing people are patients of hepatitis, estimated 170,000 new cases every year to add to the 11.5 million patients suffering from the disease. The National Committee for Control of Viral Hepatitis (NCCVH), the Egyptian government, the public, NGOs, Foreign organizations, the world bank, and different pharmaceutical companies are running initiatives and putting their combined effort into treating HCV. Hence, the measure of the above stakeholder will impact a positive trend in Egypt's market share in the hepatitis C testing market.
The government has launched many initiatives and policies in the healthcare sector, such as conducting the survey, establishing national guidelines & treatment centers, and increasing funding for HCV treatment by up to 90%. These steps will impact HCV treatment and expand the market demand for hepatitis C testing. All the factors mentioned above are expected to drive the expansion of the Hepatitis C Testing Market share.
Lack of Resources
In developing countries like Egypt, NAT Nucleic Acid Amplification Testing is not mandatory due to high costs and the need for high-skilled staff. Price is an essential factor while using and buying any product. If the overall cost is calculated, the labor and testing kit becomes an expensive product.
Merger and Collaboration with international institutions to propel market share
In this market collaboration, a merger is the best method to enter the new market. These help the market use the organization's expertise and others to gather the latest market share.
In December 2021, Roche Egypt LLC and Microsoft Corporation signed MoU. It will help companies improve patient health care using AI & cloud technology and grow their market in the Middle East.
In 2013, The American University in Cairo announced to launch of Egypt's first university spinoff company, 'D-Kimia.' It helps management enter a new market with products or technologies developed at universities in Egypt.
Market Segmentation
Egypt Hepatitis C Testing Market is segmented based on Test, Technique, and End User. Based on the test, the market is divided into Antibody Tests, Genotype Test, Viral Load Tests, and Others. Based on technique, the market is divided into Immunoassays, Polymerase Chain Reactions (PCR), and Others. Based on End Users, the market is divided into Hospitals & Clinics, Diagnostic Laboratories, and Others by company.
Market Players
D-Kimia Diagnostic Solutions, Roche Egypt LLC, Abbott Diagnostic Division Egypt, Qiagen Egypt, Siemens Healthineers Egypt, Bio-Rad Laboratories Egypt, and Thermo Fischer Scientific Egypt are the major market player in Egypt hepatitis C testing market.
Report Scope:
In this report, Egypt Hepatitis C Testing Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
- Egypt Hepatitis C Testing Market, by test:
- Antibody Test
- Genotype Test
- Viral Load Test
- Others
- Egypt Hepatitis C Testing Market, by technique:
- Immunoassays
- Polymerase Chain Reaction (PCR)
- Others
- Egypt Hepatitis C Testing Market, by End User type:
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
- Egypt Hepatitis C Testing Market, by region
- Cairo,
- Alexandria,
- Giza Qalyubia,
- Port Said Suez,
- Rest of Egypt
Company Profiles: Detailed analysis of the major companies present in Egypt Hepatitis C Testing Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON EGYPT HEPATITIS C TESTING MARKET
4. VOICE OF CUSTOMER
5. EXECUTIVE SUMMARY
6. EGYPT HEPATITIS C TESTING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test (Antibody Test, Genotype Test, Viral Load Test, Others)
6.2.2. By Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others)
6.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Product Market Map
7. EGYPT HEPATITIS C ANTIBODY TEST MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By End User
8. EGYPT HEPATITIS C GENOTYPE TEST MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By End User
9. EGYPT HEPATITIS C VIRAL LOAD TEST MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. EGYPT ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. D-Kimia Diagnostic Solutions
14.2. Roche Egypt LLC
14.3. Abbott Diagnostic Division Egypt
14.4. Qiagen Egypt
14.5. Siemens Healthineers Egypt
14.6. Bio-Rad Laboratories Egypt
14.7. Thermo Fischer Scientific Egypt
15. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. IMPACT OF COVID-19 ON EGYPT HEPATITIS C TESTING MARKET
4. VOICE OF CUSTOMER
5. EXECUTIVE SUMMARY
6. EGYPT HEPATITIS C TESTING MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Test (Antibody Test, Genotype Test, Viral Load Test, Others)
6.2.2. By Technique (Immunoassays, Polymerase Chain Reaction (PCR), Others)
6.2.3. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Product Market Map
7. EGYPT HEPATITIS C ANTIBODY TEST MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technique
7.2.2. By End User
8. EGYPT HEPATITIS C GENOTYPE TEST MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technique
8.2.2. By End User
9. EGYPT HEPATITIS C VIRAL LOAD TEST MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technique
9.2.2. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
12. POLICY & REGULATORY LANDSCAPE
13. EGYPT ECONOMIC PROFILE
14. COMPETITIVE LANDSCAPE
14.1. D-Kimia Diagnostic Solutions
14.2. Roche Egypt LLC
14.3. Abbott Diagnostic Division Egypt
14.4. Qiagen Egypt
14.5. Siemens Healthineers Egypt
14.6. Bio-Rad Laboratories Egypt
14.7. Thermo Fischer Scientific Egypt
15. STRATEGIC RECOMMENDATIONS
